Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Methylation in Determining the Fate of Dental Mesenchymal Stem Cells. | Stem Cells Int | 2022 | 36187229 | PubTator, text mining | PubMed |
| Overall survival nomogram and relapse-related factors of clear cell sarcoma of the kidney: A study based on published patients. | Front Pediatr | 2022 | 36186639 | PubTator, text mining | PubMed |
| Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia. | Front Oncol | 2022 | 36185232 | PubTator, text mining | PubMed |
| Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'. | Eur J Cancer | 2022 | 36182817 | PubTator, text mining | PubMed |
| Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A. | Discov Oncol | 2022 | 36181613 | PubTator, text mining | PubMed |
| TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review. | Ann Hematol | 2022 | 36181538 | PubTator, text mining | PubMed |
| Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). | Cancer Manag Res | 2022 | 36176694 | PubTator, text mining | PubMed |
| Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data. | Nat Commun | 2022 | 36175409 | PubTator, text mining | PubMed |
| Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification. | Front Oncol | 2022 | 36172164 | PubTator, text mining | PubMed |
| Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. | J Immunother Cancer | 2022 | 36167467 | PubTator, text mining | PubMed |
| B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers. | Mol Cancer Res | 2022 | 36166198 | PubTator, text mining | PubMed |
| Molecular classification of soft tissue sarcomas for adequate diagnosis: A study on the northeast population of Morocco. | Heliyon | 2022 | 36164527 | PubTator, text mining | PubMed |
| Systemic treatment for primary malignant sarcomas arising in craniofacial bones. | Front Oncol | 2022 | 36158667 | PubTator, text mining | PubMed |
| Antibiotic and glucocorticoid-induced recapitulated hematological remission in acute myeloid leukemia: A case report and review of literature. | World J Clin Cases | 2022 | 36158489 | PubTator, text mining | PubMed |
| BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation. | Case Rep Oncol | 2022 | 36157689 | PubTator, text mining | PubMed |
| New methodology of TMB assessment from tissue and liquid biopsy in NSCLC. | PLoS One | 2022 | 36155654 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia. | Bone Marrow Transplant | 2022 | 36151367 | PubTator, text mining | PubMed |
| Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies. | Blood Adv | 2022 | 36150050 | PubTator, text mining | PubMed |
| Causes and Pathophysiology of Acquired Sideroblastic Anemia. | Genes (Basel) | 2022 | 36140729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=46